51 Results for "

AMPA/kainate receptor

" in MedChemExpress (MCE) Product Catalog:
Products (51)

51 Results for "AMPA/kainate receptor" in MCE Product Catalog:

23
23 Publications Verification
Cat. No.: HY-15066
CAS No.: 115066-14-3
Purity:  99.38%
Synonyms: FG9065
Target:  

iGluR

Research Areas:  

Neurological Disease

CNQX (FG9065) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. CNQX is a competitive non-NMDA receptor antagonist . CNQX blocks the expression of fear-potentiated startle in rats .
loading...
    loading...
23
23 Publications Verification
Cat. No.: HY-15066A
CAS No.: 479347-85-8
Purity:  99.95%
Synonyms: FG9065 disodium
Target:  

iGluR

Research Areas:  

Neurological Disease

CNQX disodium (FG9065 disodium) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. CNQX disodium is a competitive non-NMDA receptor antagonist . CNQX disodium blocks the expression of fear-potentiated startle in rats .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15067
CAS No.: 2379-57-9
Purity:  99.26%
Synonyms: FG 9041
Target:  

iGluR

Research Areas:  

Cancer

DNQX (FG 9041), a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-103233
CAS No.: 1312992-24-7
Synonyms: FG 9041 disodium salt
Target:  

iGluR

Research Areas:  

Cancer

DNQX (FG 9041) disodium salt, a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively) .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-B0122
CAS No.: 97240-79-4
Synonyms: McN 4853; RWJ 17021
Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101165
CAS No.: 2259-96-3
Purity:  98.29%
Target:  

iGluR GABA Receptor

Research Areas:  

Neurological Disease

Cyclothiazide is a positive allosteric modulator of ionotropic AMPA-type glutamate receptors. Cyclothiazide inhibits GABAA receptors. Cyclothiazide is frequently used to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current. Cyclothiazide can potentiate responses to kainate in hippocampal neurons. Cyclothiazide has effects on glutamatergic neurotransmission. Cyclothiazide also induces epileptiform EEG activity accompanying behavioral seizures .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14608S5
CAS No.: 55443-55-5
Purity:  ≥98.0%
L-Glutamic acid- 13C5 is the 13C-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18663
CAS No.: 199655-36-2
Target:  

iGluR

Research Areas:  

Neurological Disease

CP-465022 is a potent, and selective noncompetitive AMPA receptor antagonist with anticonvulsant activity. CP-465022 is against Kainate-induced response with an IC50 of 25 nM in rat cortical neurons. CP-465022 provides a new tool to investigate the role of AMPA receptors in physiological and pathophysiological processes .
loading...
    loading...
Cat. No.: HY-14608S7
CAS No.: 2784-50-1
Purity:  99.8%
L-Glutamic acid-d5 is the deuterium labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-14608S8
CAS No.: 203805-84-9
Purity:  98.00%
L-Glutamic acid-d3 is the deuterium labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-14608S3
CAS No.: 202468-31-3
Purity:  99.9%
L-Glutamic acid- 13C5, 15N is the 13C- and 15N-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-108497
CAS No.: 217480-26-7
Purity:  95.42%
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease Cancer

L-803087 is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM. L-803087 is >280-fold higher than other somatostatin receptors. L-803087 facilitates AMPA-mediated hippocampal synaptic responses in vitro and increases kainate-induced seizures in mice .
loading...
    loading...
Cat. No.: HY-14608S
CAS No.: 115473-51-3
L-Glutamic acid- 13C is the 13C-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-103234A
CAS No.: 2319722-40-0
Purity:  99.75%
Target:  

iGluR

Research Areas:  

Neurological Disease

GYKI 52466 dihydrochloride is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively. GYKI 52466 dihydrochloride has good blood brain barrier permeability and anticonvulsant effect. GYKI 52466 dihydrochloride can be used in Parkinson's disease research .
loading...
    loading...
Cat. No.: HY-12499
CAS No.: 21416-43-3
Purity:  98.93%
Synonyms: (-)-Willardiine
Target:  

iGluR

Research Areas:  

Neurological Disease

(S)-Willardiine ((-)-Willardiine) is a subtype-selective glutamate receptor agonist and the active isomer of Willardiine. Willardiine binds to and activates hGluR1, hGluR2, hGluR4 and hGluR5, with Ki values of 3.6 nM and 0.24 nM for hGluR4 and hGluR5, respectively. (S)-Willardiine is used to investigate the distribution and physiological functions of glutamate receptor subunits in the central nervous system .
loading...
    loading...
Cat. No.: HY-14608S2
CAS No.: 21160-87-2
Purity:  ≥98.0%
L-Glutamic acid- 15N is the 15N-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals .
loading...
    loading...
Cat. No.: HY-14608S1
CAS No.: 81201-99-2
Purity:  ≥99.0%
L-Glutamic acid-1- 13C is the 13C-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-107606A
Purity:  97.48%
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP301 hydrochloride is a potent and selective antagonist of kainate receptor with IC50 and KD of 164 μM and 5.94 μM, respectively. UBP301 hydrochloride has ~30-fold selectivity of kainate receptor over AMPA receptor. UBP301 hydrochloride is the derivative of willardiine .
loading...
    loading...
Cat. No.: HY-16713A
CAS No.: 1321546-70-6
Synonyms: (5S)-Fluorowillardiine hydrochloride; (S)-5-Fluorowillardiine hydrochloride
Target:  

iGluR

Research Areas:  

Neurological Disease

(S)-(-)-5-Fluorowillardiine ((5S)-Fluorowillardiine; (S)-5-Fluorowillardiine) hydrochloride is a potent, highly selective non-NMDA ionotropic glutamate receptor (iGluR, AMPA/Kainate receptor) agonist . (S)-(-)-5-Fluorowillardiine hydrochloride activates high-affinity AMPA-preferring receptors (EC50 = 0.70 μM) and low-affinity kainate-preferring receptors (EC50 = 170 μM), thereby inducing biphasic dose-dependent neurotoxicity/excitotoxicity. (S)-(-)-5-Fluorowillardiine hydrochloride is applicable to research related to schizophrenia, temporal lobe epilepsy, and bipolar disorder .
loading...
    loading...
Cat. No.: HY-15071
CAS No.: 154164-30-4
Purity:  98.32%
Target:  

iGluR

Research Areas:  

Neurological Disease

YM90K is a potent and selective AMPA receptor antagonist with a Ki of 84 nM. YM90K is less potent in inhibiting kainate (Ki of 2.2 μM) and NMDA (Ki of 37 μM) receptors. YM90K has neuroprotective actions .
loading...
    loading...